NewcelX (formerly NLS Pharma) — Post-IPO Equity
NewcelX (formerly NLS Pharma) raised $10.0M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- NewcelX (formerly NLS Pharma)
- Round Type
- Post-IPO Equity
- Amount Raised
- $10.0M
- Announced
- December 7, 2022
Canonical: https://fsome.com/funding/newcelx-formerly-nls-pharma-post-ipo-equity-6683094 · For the full investor list, press references, and related rounds, please enable JavaScript.